Compare USNA & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | USNA | ANGO |
|---|---|---|
| Founded | 1992 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 362.9M | 400.8M |
| IPO Year | 1996 | 2004 |
| Metric | USNA | ANGO |
|---|---|---|
| Price | $20.08 | $13.29 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $36.00 | $19.33 |
| AVG Volume (30 Days) | 174.4K | ★ 506.9K |
| Earning Date | 10-22-2025 | 01-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.90 | N/A |
| Revenue | ★ $912,670,000.00 | $300,718,000.00 |
| Revenue This Year | $9.87 | $8.18 |
| Revenue Next Year | N/A | $5.15 |
| P/E Ratio | $22.20 | ★ N/A |
| Revenue Growth | ★ 5.88 | 2.73 |
| 52 Week Low | $18.48 | $7.44 |
| 52 Week High | $38.85 | $13.99 |
| Indicator | USNA | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 49.57 | 63.06 |
| Support Level | $19.33 | $13.23 |
| Resistance Level | $20.40 | $13.99 |
| Average True Range (ATR) | 0.58 | 0.47 |
| MACD | 0.22 | 0.08 |
| Stochastic Oscillator | 83.55 | 71.42 |
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.